Franklin Street Properties Corp Q4 2025 Earnings Strong EPS Beat Exceeds Expectations Amidst Office Market Challenges ESAB Q1 2026 Earnings EPS Miss Weighs on Sentiment Despite Resilient Operations CRIS Q1 2026 Earnings Significant EPS Miss as Biotech Advances Pipeline Without Revenue Dermata Therapeutics Q1 2026 Earnings NarrowerthanExpected Loss Supports Ongoing Clinical Development EXPE Q1 2026 Earnings Strong EPS Beat Amid Revenue Uncertainty MSA Safety Q1 2026 Earnings EPS Surprises Positively as Industrial Demand Holds Steady